Mr Anwar Mghari, FNP | |
106 Davis Dr, River Edge, NJ 07661-1702 | |
(201) 655-9297 | |
Not Available |
Full Name | Mr Anwar Mghari |
---|---|
Gender | Male |
Speciality | Nurse Practitioner - Family |
Location | 106 Davis Dr, River Edge, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1033452487 | NPI | - | NPPES |
1033452487 | Other | NY | REGISTERED NURSE |
363LF0000X | Other | NY | FAMILY NURSE PRACTITIONER |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 725688 (New York) | Secondary |
363LF0000X | Nurse Practitioner - Family | 351610 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Anwar Mghari, FNP 106 Davis Dr, River Edge, NJ 07661-1702 Ph: (201) 655-9297 | Mr Anwar Mghari, FNP 106 Davis Dr, River Edge, NJ 07661-1702 Ph: (201) 655-9297 |
News Archive
There is no significant disparity in the odds for US women undergoing cesarean section delivery rather than vaginal delivery according to whether they are privately or publicly Medicaid-insured patients, show study results from Michigan, USA.
Whether it's an on-line quiz, a $300 chromosome test or an $800 blood panel, a lot of people seem to be interested in whether they're aging faster or slower than their chronological age would suggest.
New research shows that patients have a much better chance of survival when both their hospital and their physician have a strong track record in treating heart attack with angioplasty and stenting.
News on the progress of a new trial may give new hope to patients with HIV who are dependent on anti-HIV drugs. The AIDS Research Consortium of Atlanta has received approval to begin enrollment of the first therapeutic trial ever conducted using a promising HIV vaccine candidate from Atlanta-based, GeoVax Inc, a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase II protocol for the clinical study of Archexin as a treatment of ovarian cancer to the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago
Theresa A Schulze, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 63 Grand Ave, River Edge, NJ 07661 Phone: 201-487-2900 Fax: 201-487-1022 | |
Mathew Testino, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9 June Ct, River Edge, NJ 07661 Phone: 201-951-0180 | |
Maria Nunzia Petruzzelli, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 Kinderkamack Rd Ste 300, River Edge, NJ 07661 Phone: 201-489-2727 Fax: 201-489-5040 |